Cargando…

Harnessing the Microbiome to Enhance Cancer Immunotherapy

The microbiota plays a key role in regulating the innate and adaptive immune system. Herein, we review the immunological aspects of the microbiota in tumor immunity in mice and man, with a focus on toll-like receptor (TLR) agonists, vaccines, checkpoint modulators, chemotherapy, and adoptive T cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nelson, Michelle H., Diven, Marshall A., Huff, Logan W., Paulos, Chrystal M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458560/ https://www.ncbi.nlm.nih.gov/pubmed/26101781 http://dx.doi.org/10.1155/2015/368736

Ejemplares similares

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning
por: Nelson, Michelle H., et al.
Publicado: (2016)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
por: Bowers, Jacob S., et al.
Publicado: (2019)

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)

Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
por: Bastos, Ana Raquel, et al.
Publicado: (2023)

Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
por: Rangel Rivera, Guillermo O., et al.
Publicado: (2021)

Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
por: Hannon, Gary, et al.
Publicado: (2023)

Harness the functions of gut microbiome in tumorigenesis for cancer treatment
por: Lee, Mong‐Hong
Publicado: (2021)

Harnessing tumor-associated macrophages as aids for cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2019)

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
por: Sulsenti, Roberta, et al.
Publicado: (2023)

Harnessing machine learning for development of microbiome therapeutics
por: McCoubrey, Laura E., et al.
Publicado: (2021)

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
por: Gu, Yuanzhuo, et al.
Publicado: (2023)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022)

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
por: Drakes, Maureen L, et al.
Publicado: (2014)

Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
por: Amon, Lukas, et al.
Publicado: (2020)

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
por: Rajani, Karishma R., et al.
Publicado: (2015)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Harnessing immunological targets for COVID-19 immunotherapy
por: Mehata, Abhishesh Kumar, et al.
Publicado: (2021)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy
por: Hino, Christopher, et al.
Publicado: (2023)

Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
por: Bae, Jihong, et al.
Publicado: (2022)

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
por: Mercogliano, María Florencia, et al.
Publicado: (2021)

Harnessing the microbiome for human health
por: O'Neill, Shanyn, et al.
Publicado: (2018)

Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Harnessing host–virus evolution in antiviral therapy and immunotherapy
por: Heaton, Steven M
Publicado: (2019)

Th17 Cells in Cancer: The Ultimate Identity Crisis
por: Bailey, Stefanie R., et al.
Publicado: (2014)

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy
por: Nabergoj, Sanja, et al.
Publicado: (2018)

Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
por: Mhibik, Maissa, et al.
Publicado: (2019)

Harnessing agricultural microbiomes for human pathogen control
por: Brennan, Fiona P., et al.
Publicado: (2022)

Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
por: Paulos, Chrystal M, et al.
Publicado: (2006)

Harnessing the Microbiome to Optimize Surgical Outcomes in the COVID-19 Era
por: Toni, Tiffany, et al.
Publicado: (2021)

HOW TO HARNESS NEW IMMUNOTHERAPIES WITH COMBINATION STRATEGIES?
por: Einsele, H.
Publicado: (2023)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
por: La Manna, Marco P., et al.
Publicado: (2020)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies
por: St-Pierre, Frederique, et al.
Publicado: (2021)

Harnessing the microbiome to control plant parasitic weeds
por: Masteling, Raul, et al.
Publicado: (2019)

Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review
por: Najmi, Maleka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0l010dhqa9kemfu1755p316o3